Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 965 Cr.
- Current Price ₹ 32.2
- High / Low ₹ 33.2 / 18.3
- Stock P/E 14.0
- Book Value ₹ 16.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 63.0 days to 45.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Part of BSE Fast Moving Consumer Goods
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | 1,768 | |
| 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | 1,622 | |
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 | 147 |
| OPM % | 6% | 4.3% | 3.6% | 6% | 7% | 8% | 9% | 8% | 8% |
| 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | 31 | |
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 | 59 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 | 18 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 | 100 |
| Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% | 24% | |
| 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | 74 | |
| EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | 1.74 | 2.31 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 7% |
| TTM: | 76% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 53% |
| 3 Years: | 6% |
| TTM: | 59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 14% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 | |
| 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 | |
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 | |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 31 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 | |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 | |
| -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 | |
| 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 | |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -130 | -230 |
| CFO/OP | -67% | -81% | 29% | 22% | -52% | -118% | -114% | -84% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working Capital Days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
| ROCE % | 15% | 9% | 18% | 24% | 19% | 12% | 12% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
|||||
| Number of Customers Served count |
||||||
| Fish Meal Capacity Utilization % |
||||||
| Fish Meal Installed Capacity MT/year |
||||||
| Fish Meal Production Volume MT |
||||||
| Fish Oil Production Volume MT |
||||||
| Top 10 Customer Concentration % |
||||||
| Insect Protein Wet Waste Processed Tons |
||||||
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Intimation Of Outcome Of 16Th AGM.
- AGM approved 5-year reappointments of three independent directors, MD/CEO, CFO and COO from 2027.
- Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Announcement under Regulation 30 (LODR)-Allotment
- Board allotted 2 crore convertible warrants at Rs 23.50 each, raising Rs 47 crore on 10-09-2026.
-
Intimation Of Receipt Of EU - Inputs Attestation.
- Mukka Proteins received EU Inputs Attestation for Eco Sphere Organic Fertilizer, valid until March 31, 2028.
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries